Missouri – Harbor Healthcare Mergers & Acquisitions, a leading advisory firm specializing in compounding pharmacy transactions, is pleased to announce the successful sale of Skin Specialty Solutions 503A compounding pharmacy, a key pharmacy services provider to Curology, to a nationwide strategic acquirer. The transaction marks an important step in expanding the buyer’s operational capacity and capabilities, enabling broader geographic reach and enhanced service to an increasing provider base via the 50-state licensed, non-sterile USP 800 accredited facility.
Skin Specialty Solutions’ adept team of pharmacists, technicians and specialists, built a strong reputation for delivering high-quality, patient-specific compounded medications, particularly in partnership with Curology, a leader in custom skincare and hair loss solutions. The business represents a state-of-the-art facility that harmonizes technology and software to provide efficient pharmaceutical services to customers and patients.
Mark Alford, Managing Director at Harbor Healthcare, expressed his enthusiasm for the transaction, saying, “M&A activity in the compounding pharmacy market is very active at the moment and sellers are presented with rare opportunities to create generational wealth. Sterile and non-sterile pharmacies are both in high demand and numerous buyers are actively seeking acquisitions. Skin Specialty Solutions played a critical role in the compounding space, and this acquisition will allow the buyer to continue that legacy while expanding their operational capabilities and customer reach.”
The buyer also shared their excitement, stating, “This acquisition is a key milestone in our strategy to increase capacity and serve a broader range of providers and patients in new markets. We are excited to integrate Skin Specialty Solutions’ staff and facility into our operations and continue to exceed the high standards of care patients deserve.”
A representative from Skin Specialty Solutions expressed optimism for the future, noting, “We are confident that the new ownership will build on our foundation and further enhance the services we’ve provided to our patients. This transaction ensures that our mission of providing high-quality compounded medications will continue to thrive and expand.”
Harbor Healthcare acted as the exclusive sell-side advisor to Skin Specialty Solutions in this transaction.
About Harbor Healthcare
Harbor Healthcare is a boutique M&A advisory firm founded in 1995. Harbor offers a variety of M&A advisory services to middle market healthcare and pharmacy businesses. The company provides perceptive strategic solutions to independent owners and investors of long-term care, specialty, infusion, compounding and 340B pharmacies. Harbor offers regulatory and advisory expertise while maintaining business relationships with strategic, private equity and independent acquirers. For more information, please contact Mark Alford, Managing Director at Harbor Healthcare (619) 535-9005 or visit https://www.harborhealthcare.com.
Click Here for a Sample of Our M&A Transactions
Select Transactions